Antidiabetic effect of a new peptide from Squalus mitsukurii liver (S-8300) in alloxan-diabetes

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 7, 2005, Pages 521-525

  Huang, Fengjie ^a   Wu, Wutong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Alloxan diabetes; Antidiabetic effect; S 8300

Indexed keywords

ALLOXAN; ANTIDIABETIC AGENT; CHOLESTEROL; FATTY ACID; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIVER EXTRACT; MALONALDEHYDE; S 8300; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; LIPID; PEPTIDE; PEPTIDE S 8300; PEPTIDE S-8300;

ALLOXAN DIABETES MELLITUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BODY WEIGHT; CELL DAMAGE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; LIVER; MOUSE; NONHUMAN; PANCREAS ISLET; SHARK; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; INSTITUTE FOR CANCER RESEARCH MOUSE; KIDNEY; METABOLISM; PANCREAS; PATHOLOGY; SQUALUS; TIME;

ALLOXAN; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; HEMOGLOBIN A, GLYCOSYLATED; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LIPIDS; LIVER; LIVER EXTRACTS; MICE; MICE, INBRED ICR; PANCREAS, EXOCRINE; PEPTIDES; SQUALUS; TIME FACTORS;

EID: 22544450479     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04224.x     Document Type: Article

References (16)

1. Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J. Ethnopharmacol 2004; 92: 1-21.
2. Pari L, Amarnath Satheesh M. Antidiabetic activity of Boerhaavia diffusa L: Effect on hepatic key enzymes in experimental diabetes. J. Ethnopharmacol. 2004; 91: 109-13.
3. Lemhadri A, Zeggwagh N-A, Maghrani M, Jouad H, Eddouks M. Anti-hyperglycaemic activity of the aqueous extract of Origanum vulgare growing wild in Tafilalet region. J. Ethnopharmacol. 2004; 92: 251-6.
4. Stanely Mainzen Prince P, Kamalakkannan N, Menon VP. Anti-diabetic and antihyperlipidaemic effect of alcoholic Syzigium cumini seeds in alloxan induced diabetic albino rats. J. Ethnopharmacol. 2004; 91: 209-13.
5. Huang FJ, Li Q, Lü Z-B, Wu W-T. Protective effect of peptide S-8300 from shark liver on acute liver injury in mice. Zhongguo Haiyang Yaowu 2004; 97: 17-20 (in Chinese).
6. Antonio F, Peter O, Lorenzo P et al. Extraction and partial purification of a hepatic stimulatory substance in rats, mice, and dogs. Cancer Res. 1987; 47: 5600-5.
7. Hong G, Wu G-Z, Liu G-Q. Protective effects of shark hepatic stimulator substance on alloxan-induced diabetes in mice. J. China Pharm. Univ. 2003; 34: 155-9 (in Chinese).
8. Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and haemoglobin Alc in diabetes mellitus. N. Engl. J. Med. 1976; 295: 417-20.
9. Jackson RL, Hess RL, England JD. Haemoglobin Alc values in children with over diabetes maintained in varying degree of correct. Diabetes Care 1979; 2: 391-5.
10. Stanely Mainzen Prince P, Menon VP, Pari L. Hypoglycaemic activity of Syzigium cumini seeds: Effect on lipid peroxidation in alloxan diabetic rats. J. Ethnopharmacol. 1998; 61: 1-7.
11. Shirwaikar A, Rajendran K, Kumar CD, Bodla R. Antidiabetic activity of aqueous leaf extract of Annona squamosa in streptozotocin-nicotinamide type 2 diabetic rats. J. Ethnopharmacol. 2004; 91: 171-5.
12. John WB. Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405.
13. Halliwell B, Gutteridge JMC. Free Radicals in Biology and Medicine. Oxford Clarendon Press, London. 1985.
14. Babior MB. Oxygen-dependent microbial killing by phagocytes. N. Engl J. Med. 1978; 298: 659-68.
15. Akkus I, Kalak S, Vural H et al. Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leudismutase vitamin C levels of patients with type II diabetes mellitus. Clin. Chim. Acta 1996; 244: 221-7.
16. Delamire M, Maugendre D, Moreno M, Le Goff MC, Allannic H, Genetet B. Impaired leucocyte functions in diabetic patients. Diabet. Med. 1997; 14: 29-34.